首頁 > 市場調查報告書 > 製藥

藥物開發

藥物發現市場規模、佔有率和成長分析（按流程、藥物類型、技術、治療領域、服務供應商和地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1900440

藥物發現市場規模、佔有率和成長分析（按流程、藥物類型、技術、治療領域、服務供應商和地區分類）－2026-2033年產業預測

Drug Discovery Market Size, Share, and Growth Analysis, By Process (Target Selection, Target Validation), By Drug Type, By Technology, By Therapeutic Area, By Service Provider, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月18日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球藥物研發市場預計到 2024 年將達到 804.2 億美元，到 2025 年將達到 882.2 億美元，到 2033 年將達到 1850.2 億美元，預測期（2026-2033 年）的複合年成長率為 9.7%。

在全球疾病發病率上升、技術進步以及對個人化醫療需求激增的推動下，全球藥物研發市場正經歷顯著的成長和創新。研發活動日益密集，重點在於發現新的藥物標靶和開發有效的治療方法。基因組學、蛋白質組學和計算生物學等多個領域的融合，使研究人員能夠更深入地了解疾病機制，並加速藥物研發進程。此外，高通量篩檢、人工智慧和巨量資料分析等先進技術的應用，正在提高藥物研發的效率和成功率。隨著精準醫療和標靶治療日益受到重視，全球藥物研發市場預計將迎來顯著成長。

全球藥物研發市場促進因素

推動全球藥物研發市場發展的關鍵因素是慢性病和感染疾病的日益普及。癌症、心血管疾病和各種感染疾病等疾病發生率的不斷上升，凸顯了對創新有效治療方案的迫切需求。這種日益成長的需求迫使製藥公司和研究機構將資源投入藥物舉措，從而促進研發進展，旨在開發新的治療方法方法以應對這些緊迫的健康挑戰。因此，對克服這些醫療挑戰的關注為藥物研發領域的投資和創新創造了有利環境。

全球藥物研發市場面臨的限制因素

全球藥物研發市場面臨的一大挑戰是藥物研發過程高成本且耗時漫長。從最初的化合物發現到最終核准，都需要在研究、臨床試驗以及法規核准等方面投入大量資金。這種複雜的法規結構，加上嚴格的安全性和有效性標準，導致藥物研發週期漫長。這些因素增加了新藥上市的成本，最終可能影響患者和醫療服務提供者獲得藥物的便利性和可負擔性。

全球藥物研發市場趨勢

全球藥物研發市場的一大顯著趨勢是人工智慧 (AI) 和機器學習 (ML) 技術的日益普及。這些先進工具能夠有效率且自動化地分析大量資料集，進而改變藥物研發格局。 AI 和 ML 演算法擅長解讀複雜的生物資訊、識別複雜的模式以及預測藥物與標靶的相互作用，從而顯著縮短藥物研發週期。此外，AI 驅動的虛擬篩檢和分子建模能夠提高識別潛在候選藥物的準確性。這些先進技術的整合可望提高藥物研發專案的效率、降低成本並提升成功率，進而促進創新高效療法的研發。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Thermo Fisher Scientific Inc
Merck & Co., Inc.
Curia Global（Albany Molecular Research Inc.）
Charles River Laboratories
Evotec SE
Jubilant Life Sciences
Labcorp（Convance, Inc.）
GenScript Biotech Corporation
Dr. Reddy's Laboratories Limited（Aurigene）
WuXi AppTec
Biocon Ltd（Syngene International Ltd）
SRI International
Viva Biotech Holdings
Domainex
Eurofins Scientific SE
Hongkong Tigermed Co., Limited（Frontage Holdings Corporation）
Piramal Pharma Ltd.
Shanghai Medicilon Inc
Sygnature Discovery
Selvita SA

結論與建議

簡介目錄

Product Code: SQMIG35H2100

Global Drug Discovery Market size was valued at USD 80.42 Billion in 2024 and is poised to grow from USD 88.22 Billion in 2025 to USD 185.02 Billion by 2033, growing at a CAGR of 9.7% during the forecast period (2026-2033).

The Global Drug Discovery market is undergoing notable growth and innovation, fueled by an escalating incidence of diseases, technological advancements, and a surge in demand for personalized medicine. This market is experiencing intensified research and development activities focused on uncovering novel drug targets and formulating effective therapeutics. The convergence of diverse fields, including genomics, proteomics, and computational biology, is providing researchers with enhanced insights into disease mechanisms, thereby accelerating the drug discovery process. Furthermore, the application of cutting-edge technologies such as high-throughput screening, artificial intelligence, and big data analytics is improving both the efficiency and success rates in drug development. With an increasing emphasis on precision medicine and targeted therapies, the Global Drug Discovery market is set for substantial growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Drug Discovery market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Drug Discovery Market Segments Analysis

Global Drug Discovery Market is segmented by Process, Drug Type, Technology, Therapeutic Area, Service Provider and region. Based on Process, the market is segmented into Target Selection, Target Validation, Hit-To-Lead Identification, Lead Optimization and Candidate Validation. Based on Drug Type, the market is segmented into Small Molecule Drugs and Large molecule drug/Biologic Drugs. Based on Technology, the market is segmented into High Throughput Screening, Pharmacogenomics, Nanotechnology, Combinational Chemistry, AI/ML in Drug Discovery and Others. Based on Therapeutic Area, the market is segmented into Oncology, Neurology, Infectious Diseases, Metabolic Disorders, Cardiology, Gastroenterology, Pulmonology and Others. Based on Service Provider, the market is segmented into Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROs), Research Centers and Academic and Government and Public Health Agencies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Drug Discovery Market

A key factor propelling the Global Drug Discovery market is the rising prevalence of chronic and infectious diseases. The growing occurrence of conditions like cancer, cardiovascular diseases, and various infectious ailments underscores an urgent demand for innovative and effective therapeutic solutions. This heightened need compels pharmaceutical companies and research institutions to allocate resources towards drug discovery initiatives, fostering advancements in R&D aimed at developing novel treatments and therapies that cater to these pressing health challenges. Consequently, the focus on overcoming these medical hurdles creates an environment ripe for investment and innovation within the drug discovery sector.

Restraints in the Global Drug Discovery Market

A significant challenge facing the Global Drug Discovery market is the elevated costs and lengthy duration associated with the drug development process. The journey from the initial discovery of a compound to securing market approval demands considerable investment in research, clinical trials, and navigating regulatory pathways. This intricate regulatory framework, coupled with rigorous safety and efficacy standards, contributes to the protracted timelines involved in drug development. Such factors can drive up the expenses associated with bringing new drugs to market, ultimately impacting their accessibility and affordability for patients and healthcare providers alike.

Market Trends of the Global Drug Discovery Market

A prominent trend in the Global Drug Discovery market is the increasing adoption of artificial intelligence (AI) and machine learning (ML) technologies. These cutting-edge tools are transforming the drug discovery landscape by allowing for the efficient and automated analysis of vast datasets. AI and ML algorithms excel at dissecting complex biological information, identifying intricate patterns, and predicting drug-target interactions, thus significantly shortening the drug discovery timeline. Additionally, AI-driven virtual screening and molecular modeling enhance precision in identifying viable drug candidates. This integration of advanced technologies is set to bolster efficiency, curtail costs, and elevate the success rates of drug development programs, driving the emergence of innovative and effective therapeutics.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Technology Analysis
Case Studies
Startup Analysis
Pipeline Analysis
Clinical Trial Analysis
Partnership Analysis

Global Drug Discovery Market Size by Process & CAGR (2026-2033)

Market Overview
Target Selection
Target Validation
Hit-To-Lead Identification
Lead Optimization
Candidate Validation

Global Drug Discovery Market Size by Drug Type & CAGR (2026-2033)

Market Overview
Small Molecule Drugs
Large molecule drug/Biologic Drugs

Global Drug Discovery Market Size by Technology & CAGR (2026-2033)

Market Overview
High Throughput Screening
Pharmacogenomics
Nanotechnology
Combinational Chemistry
AI/ML in Drug Discovery
Others

Global Drug Discovery Market Size by Therapeutic Area & CAGR (2026-2033)

Market Overview
Oncology
Neurology
Infectious Diseases
Metabolic Disorders
Cardiology
Gastroenterology
Pulmonology
Others

Global Drug Discovery Market Size by Service Provider & CAGR (2026-2033)

Market Overview
Pharmaceutical & Biotechnology Companies
Contract Research Organizations (CROs)
Research Centers and Academic
Government and Public Health Agencies

Global Drug Discovery Market Size & CAGR (2026-2033)

North America (Process, Drug Type, Technology, Therapeutic Area, Service Provider)
- US
- Canada
Europe (Process, Drug Type, Technology, Therapeutic Area, Service Provider)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Process, Drug Type, Technology, Therapeutic Area, Service Provider)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Process, Drug Type, Technology, Therapeutic Area, Service Provider)
- Brazil
- Rest of Latin America
Middle East & Africa (Process, Drug Type, Technology, Therapeutic Area, Service Provider)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Thermo Fisher Scientific Inc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck & Co., Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Curia Global (Albany Molecular Research Inc.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Charles River Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Evotec SE
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Jubilant Life Sciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Labcorp (Convance, Inc.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GenScript Biotech Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dr. Reddy's Laboratories Limited (Aurigene)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
WuXi AppTec
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biocon Ltd (Syngene International Ltd)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SRI International
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Viva Biotech Holdings
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Domainex
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Scientific SE
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hongkong Tigermed Co., Limited (Frontage Holdings Corporation)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Piramal Pharma Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shanghai Medicilon Inc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sygnature Discovery
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Selvita SA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments